In another positive development, Pfizer won a bid in a London court to invalidate two of GSK Plc’s GSK patents relating to its respiratorysyncytialvirus (RSV) vaccine. Also Read: UK Chooses ...
A new COVID variant, XEC, is gaining traction in the U.S. and is estimated to account for up to 13% of cases. The strain is a recombinant of two JN.1 lineage viruses, with new COVID shots expected to ...
In anticipation of the winter season an increased circulation of respiratory viruses is expected with a peak in the coming weeks – and the free fall vaccination campaign will begin soon. Quebec’s ...
Results that may be inaccessible to you are currently showing.